Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N07CA01	BETAHISTINE ARROW GENERIQUES	G	Betahistine dihydrochloride - 24mg	24mg	Tablet	749,864 L.L
C01EB17	BRADIREM	G	Ivabradine (HCl) - 5mg	5mg	Tablet, film coated	1,134,203 L.L
C01EB17	BRAVIGO	G	Ivabradine (HCl) - 5mg	5mg	Tablet, film coated	1,237,679 L.L
C01EB17	BRADIREM	G	Ivabradine (HCl) - 7.5mg	7.5mg	Tablet, film coated	1,134,203 L.L
C01EB17	BRAVIGO	G	Ivabradine (HCl) - 7.5mg	7.5mg	Tablet, film coated	1,237,679 L.L
L01DC01	BLEO-CELL	G	Bleomycin (sulfate) - 15mg	15mg	Injectable powder for solution	3,817,857 L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 500IU	500IU	Injectable powder for solution+diluent	27,390,281 L.L
L01EC03	BRAFTOVI	BioTech	Encorafenib - 50mg	50mg	Capsule, hard	70,084,833 L.L
L01EC03	BRAFTOVI	BioTech	Encorafenib - 75mg	75mg	Capsule, hard	149,227,143 L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 500IU	500IU	Injectable powder for solution+diluent	L.L
L01FF04	BAVENCIO	BioTech	Avelumab - 200mg/10ml	200mg/10ml	Injectable concentrate for solution	L.L
L03AB07	BLASTOFERON	BioTech	Interferon beta-1a - 44mcg	44mcg	Injectable solution	55,847,685 L.L
L03AB07	BLASTOFERON	BioTech	Interferon beta-1a - 22mcg	22mcg	Injectable solution	40,725,735 L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable solution	L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable solution	L.L
B03XA01	BINOCRIT	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 2,000IU/ml	2,000IU/ml	Injectable solution	6,803,873 L.L
B03XA01	BINOCRIT	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU/0.4ml	4,000IU/0.4ml	Injectable solution	5,582,795 L.L
A10AE04	BASAGLAR KWIKPEN	BioTech	Insulin glargine - 100U/ml	100U/ml	Injectable solution	4,114,846 L.L
B03XA01	BINOCRIT	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 10,000IU/ml	10,000IU/ml	Injectable solution	16,325,433 L.L
B03XA01	BINOCRIT	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 40,000IU/ml	40,000IU/ml	Injectable solution	11,726,826 L.L
L01FB01	BESPONSA FOR INJECTION	BioTech	Inotuzumab Ozogamicin - 0.9mg	0.9mg	Injectable powder for suspension	921,176,511 L.L
L01FF04	BAVENCIO	BioTech	Avelumab - 200mg/10ml	200mg/10ml	Injectable concentrate for solution	104,075,577 L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable solution	49,744,595 L.L
M03AX01	BOTOX	BioTech	Clostridium botulinum type A neurotoxin complex - 100U	100U	Injectable powder for solution	18,625,995 L.L
L01FG01	BIVASTINA 400	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	92,353,609 L.L
M03AX01	BOTOX	BioTech	Clostridium botulinum type A neurotoxin complex - 100U	100U	Injectable powder for solution	18,625,995 L.L
L01FG01	BIVASTINA 400	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	53,111,763 L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable solution	14,719,570 L.L
L01FG01	BIVASTINA 100	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	22,840,337 L.L
L01FG01	BIVASTINA 100	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	12,021,318 L.L